Jump to Main Content
Tissue regeneration in vivo within recombinant spidroin 1 scaffolds
- Moisenovich, Mikhail M., Pustovalova, Olga, Shackelford, Julia, Vasiljeva, Tamara V., Druzhinina, Tatiana V., Kamenchuk, Yana A., Guzeev, Vitaly V., Sokolova, Olga S., Bogush, Vladimir G., Debabov, Vladimir G., Kirpichnikov, Mikhail P., Agapov, Igor I.
- Biomaterials 2012 v.33 no.15 pp. 3887-3898
- Bombyx mori, Nephila clavipes, biocompatibility, giant cells, macrophages, mice, micropores, microscopy, nerve fibers, osteoclasts, polymers, rats, silk proteins, tissue engineering, tissue repair
- One of the major tasks of tissue engineering is to produce tissue grafts for the replacement or regeneration of damaged tissue, and natural and recombinant silk-based polymer scaffolds are promising candidates for such grafts. Here, we compared two porous scaffolds made from different silk proteins, fibroin of Bombyx mori and a recombinant analog of Nephila clavipes spidroin 1 known as rS1/9, and their biocompatibility and degradation behavior in vitro and in vivo. The vascularization and intergrowth of the connective tissue, which was penetrated with nerve fibers, at 8 weeks after subcutaneous implantation in Balb/c mice was more profound using the rS1/9 scaffolds. Implantation of both scaffolds into bone defects in Wistar rats accelerated repair compared to controls with no implanted scaffold at 4 weeks. Based on the number of macrophages and multinuclear giant cells in the subcutaneous area and the number of osteoclasts in the bone, regeneration was determined to be more effective after the rS1/9 scaffolds were implanted. Microscopic examination of the morphology of the matrices revealed differences in their internal microstructures. In contrast to fibroin-based scaffolds, the walls of the rS1/9 scaffolds were visibly thicker and contained specific micropores. We suggest that the porous inner structure of the rS1/9 scaffolds provided a better micro-environment for the regenerating tissue, which makes the matrices derived from the recombinant rS1/9 protein favorable candidates for future in vivo applications.